-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenaya Therapeutics Unveils Interim Data from MyClimb™ Study at ESC 2025, Offering New Insights into Pediatric MYBPC3-associated HCM Risks

Reuters·08/31/2025 14:15:16

Please log in to view news